HCW Biologics HCWB
NASDAQ HCWB
$1.16 -0.01 (-0.85%)
At close: Oct 21, 2026 · 4:00 PM EDT

HCW Biologics (HCWB) Construction in Progress (2023 - 2025)

Updated

HCW Biologics' Construction in Progress was $13.5 million in Q4 2025, unchanged from $13.5 million a year earlier.

Analysis

HCW Biologics (HCWB) Construction in Progress (2023 - 2025) Analysis & Trends

  • In earlier years, Construction in Progress was $13.5 million in FY2024 (+29.8%) and $10.4 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 HCW Biologics 1.53 Mn -4.70 Mn -93,887.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 13.50 Mn
Dec 31, 2024 13.50 Mn
Dec 31, 2023 10.40 Mn
API Access

HCW Biologics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=HCWB&period=max&api_key=YOUR_API_KEY